CAM

Cormorant Asset Management Portfolio holdings

AUM $1.34B
1-Year Est. Return 85.27%
This Quarter Est. Return
1 Year Est. Return
+85.27%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.76B
AUM Growth
+$237M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
81
New
Increased
Reduced
Closed

Top Buys

1
+$63.7M
2
+$30.9M
3
+$27.7M
4
EYPT icon
EyePoint Pharmaceuticals
EYPT
+$25.9M
5
PCVX icon
Vaxcyte
PCVX
+$19.5M

Top Sells

1
+$178M
2
+$38.4M
3
+$27.5M
4
RAIN
Rain Oncology Inc. Common Stock
RAIN
+$26M
5
GLUE icon
Monte Rosa Therapeutics
GLUE
+$22.5M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
1
$415M 23.26%
8,142,100
+1,249,999
2
$158M 8.87%
9,616,155
+1,116,155
3
$119M 6.69%
1,310,000
-50,000
4
$78.4M 4.39%
3,570,872
5
$71.7M 4.02%
4,169,179
-388,235
6
$63.2M 3.54%
2,000,000
+400,000
7
$42.6M 2.39%
4,204,364
+1,818,183
8
$41.6M 2.33%
3,800,000
+2,528,571
9
$41.4M 2.32%
1,500,000
-200,000
10
$39.5M 2.21%
1,936,133
11
$33.2M 1.86%
665,000
+390,000
12
$32.4M 1.82%
5,150,000
13
$30.9M 1.73%
+1,095,000
14
$29.8M 1.67%
10,813,246
15
$29M 1.62%
2,612,115
16
$28.7M 1.61%
2,221,739
+400,000
17
$27.8M 1.56%
3,200,000
+2,974,935
18
$27.8M 1.56%
3,082,000
19
$26.8M 1.5%
44,620
20
$25.7M 1.44%
1,421,422
21
$25.6M 1.43%
1,350,000
-1,450,000
22
$24.4M 1.37%
340,000
+40,000
23
$24M 1.34%
576,373
24
$22.8M 1.28%
2,946,887
25
$20.2M 1.13%
850,000
1
2 3 4